Neuromuscular system of parasites

The neuromuscular system of parasites is a complex physiological network comprising neurons, neurotransmitters, and muscle cells that coordinate essential behaviors such as movement, attachment, and nutrient acquisition [Martin et al., 2012]. This system is a primary focus for anthelmintic therapy because it contains several molecular targets that are either unique to parasites or significantly different from their mammalian counterparts. For instance, glutamate-gated chloride channels (GluCls) are found only in invertebrates, providing a high margin of safety for drugs like ivermectin [Wolstenholme, 2011]. The system relies on a variety of neurotransmitters, including acetylcholine, GABA, and glutamate, to regulate muscle tone and rhythmic activity. Disruption of these signaling pathways by drugs leads to either spastic or flaccid paralysis, preventing the parasite from maintaining its position within the host or feeding, which ultimately results in its death or expulsion [Geary et al., 2011]. As parasitic infections continue to pose significant global health and economic burdens, the neuromuscular system remains a critical area for the discovery of new drug classes to combat widespread resistance to existing treatments [Holden-Dye & Walker, 2014, WormBook].

Other names

Parasite neuromuscular junctionHelminth neuromuscular systemNematode neuromuscular system

Anthelmintic drugs target the neuromuscular system of parasites by modulating various ion channels and receptors. Macrocyclic lactones like ivermectin act as potent agonists of glutamate-gated chloride channels (GluCls), causing an influx of chloride ions that hyperpolarizes neurons and muscle cells, leading to flaccid paralysis [Cully et al., 1994, Nature]. Cholinergic agents such as levamisole and pyrantel serve as agonists for nicotinic acetylcholine receptors (nAChRs), inducing persistent muscle depolarization and spastic paralysis [Martin et al., 2012, British Journal of Pharmacology]. Conversely, amino-acetonitrile derivatives like monepantel target specific nematode nAChR subunits (e.g., ACR-23), while spiroindoles like derquantel act as nAChR antagonists [Kaminsky et al., 2008, Nature; Little et al., 2011, International Journal for Parasitology]. Other agents like emodepside activate latrophilin-like receptors and SLO-1 potassium channels to inhibit neuromuscular transmission [Harder et al., 2005, Parasitology Research]. Praziquantel disrupts calcium homeostasis, likely through voltage-gated calcium channel subunits, causing rapid muscle contraction [Park & Day, 2017, PLoS Neglected Tropical Diseases].